Related content

Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma

By Schöffski Patrick   Wolter Pascal   Clement Paul   Sciot Raf   De Wever Ivo   Wozniak Agnieszka   Stefan Cristiana   Dumez Herlinde  

Future Oncology, Vol. 3, Iss. 4, 2007-08 ,pp. : 381-392

Future Medicine

Access to resources Recommend Favorite

Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin): An example of potential problems for extrapolation of active drug concentrations from in vitro studies

By Tognon Gianluca   Frapolli Roberta   Zaffaroni Marco   Erba Eugenio   Zucchetti Massimo   Faircloth Glynn   D’Incalci Maurizio  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 89-90

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of four modulators of drug metabolism as protectants against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the female rat and in hepatocytes in vitro

By Donald Sarah   Verschoyle Richard   Greaves Peter   Orr Samantha   Jimeno Jose   Gescher Andreas  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 305-312

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of Yondelis(TM) (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

By Twelves C.   Hoekman K.   Bowman A.   Vermorken J.B.   Anthoney A.   Smyth J.   van Kesteren C.   Beijnen J.H.   Uiters J.   Wanders J.   Gomez J.   Guzman C.   Jimeno J.   Hanauske A.   for the New Drug Development Group of the EORTC  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1842-1851

Elsevier

Access to resources Recommend Favorite

Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment

By Fetterly Gerald   Owen Joel   Stuyckens Kim   Passarell Julie   Zannikos Peter   Soto-Matos Arturo   Izquierdo Miguel   Perez-Ruixo Juan  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 135-147

Springer Publishing Company

Access to resources Recommend Favorite